Polio: Late-Stage Management, Post-Polio Syndrome & Prevention

Acute poliomyelitis has no cure. The poliovirus destroys anterior horn motor neurons irreversibly. However, comprehensive supportive care and long-term management dramatically improve survival and function.

Acute Phase Supportive Care

• Respiratory support: Non-invasive ventilation (BiPAP) → intubation/tracheostomy if bulbar/respiratory failure. Iron lung (historical).
• Pain management: Opioids, NSAIDs, gabapentinoids for neuropathic pain.
• Prevent complications: DVT prophylaxis, skin care, nutrition (NG/PEG if bulbar), bladder/bowel management.
• Early PT/OT: Positioning, passive ROM, prevent contractures.

Late-Stage / Chronic Management

Multidisciplinary Rehabilitation

• Physical therapy: Strengthening (non-fatiguing), stretching, gait training, orthotics (AFO, KAFO), wheelchair/seating clinic.
• Occupational therapy: ADL adaptation, energy conservation, assistive tech, home modification.
• Speech-language pathology: Dysphagia management, communication aids if bulbar involvement.
• Orthopedics: Tendon transfers, osteotomies, spinal fusion (scoliosis), joint stabilization.

Post-Polio Syndrome (PPS)

• Onset: 15-40 years after acute infection; new weakness, fatigue, pain, atrophy in previously affected or "recovered" muscles.
• Pathophysiology: Terminal axonal degeneration of enlarged motor units; metabolic exhaustion; aging.
• Diagnosis: Clinical (prior polio, interval stability, new symptoms) + exclusion.
• Management: Pacing/energy conservation, non-fatiguing exercise, pain management, bracing, respiratory support (sleep-disordered breathing common).

Assistive Technology

• Custom orthoses, lightweight wheelchairs (manual/power), standing frames.
• Home automation, voice control, adaptive driving.
• Ventilatory support: BiPAP (nocturnal), volume ventilators, diaphragm pacing (phrenic nerve stimulation).

Pain Management

• Musculoskeletal (overuse, malalignment): PT, NSAIDs, topical, injections.
• Neuropathic: Gabapentin, pregabalin, duloxetine, TCAs.
• Post-polio myalgia: Warmth, pacing, avoiding overuse.

Prevention: The Ultimate Strategy

• IPV (Inactivated Polio Vaccine): 4-dose series (2, 4, 6-18 mo, 4-6 yr). 99% effective after 3 doses.
• OPV (Oral): Used in eradication campaigns (induces mucosal immunity); rare VAPP (1/2.7M doses) and cVDPV.
• Global Eradication Initiative (GPEI): Wild poliovirus type 2 & 3 eradicated; type 1 endemic only in Afghanistan & Pakistan (2024).
• Surveillance: AFP (acute flaccid paralysis) reporting, environmental (sewage) sampling.

Polio is a preventable tragedy. Vaccination protects individuals and communities. For survivors, specialized clinics (Post-Polio clinics) optimize aging with disability.